Le Lézard
Classified in: Health
Subjects: PDT, MAT

Better than CBD Alone for Pain? Lefa, Innovative New Soothing Topical Loaded with Beta-Caryophyllene and CBD Now Available for Purchase Online via LefaLabs.com


LOS ANGELES, May 21, 2020 /PRNewswire-PRWeb/ -- Labyrinthe Labs has announced the launch of its brand new and ground-breaking topical joint and muscle support formula called Lefa. A soothing cream designed for fast-action relief of joint and muscle soreness, Lefa is botanically powered by a clinically superior blend of whole plant phytocannabinoids proven to soothe and support tired joints and muscles.

According to the National Institutes of Health, approximately 25.3 million American adults suffer from daily pain and 23.4 million American adults report significant pain. Designed to support the body's natural Endocannabinoid System which is responsible for regulating inflammation and pain levels, Lefa's proprietary blend of over 3,000 mg of powerful Beta-Caryophyllene and full spectrum hemp oil with naturally occurring CBD, plus Menthol activates on contact, penetrates deep, and reacts to CB receptors in the skin for immediate and long-lasting support with your very first application.

Lefa's Full-Spectrum Hemp Oil Tincture Drops are also bountiful with naturally occurring phytocannabinoids supporting the Endocannabinoid System from the inside.

"Every new product we formulate is crafted using proven science and superior innovation providing our customers with unique solutions to an age-old ailment: joint and muscle soreness and discomfort," said Deborah Ruggerio, Director of Marketing of Labyrinthe Labs. "Whether it's age-related, sports-related or fitness-related, Lefa is great for adults who live a health-oriented lifestyle and want a natural way to support their body's Endocannabinoid System's natural response to inflammation and pain."
The new products include Joint and Muscle Pain Relief Cream and two non-GMO, vegan and gluten-free, hemp oil tinctures ? Peppermint Zen and Natural Namaste ? (300mg). All products are manufactured in a certified facility and operating under the strictest of GMP guidelines.

To learn more about Lefa and its products, visit http://www.lefalabs.com.

About Labyrinthe Labs
Labyrinthe Labs was founded in January 2020 as a complete, multi-layered product development, direct response and brand marketing operation. Its team has spent the last 20 years developing new, innovative and scientifically efficacious products with steady mass consumer appeal spanning from baby boomers all the way through millennials.

 

SOURCE Labyrinthe Labs


These press releases may also interest you

at 20:25
AHF Praises Colombia for Putting Lives Before Pharma Greed
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC Deputy Registrar, Kathy Lauriente, honoured with Distinguished Service Award from Thompson Rivers University (TRU)
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT Expands to Meet the Growing Need for Self-Harm, Suicidal Thoughts, and Depression Therapy.
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
Notice - NOVA TECH LTD and CYNTHIA PETION, File No. 2023-20
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

More news about Health...


News published on and distributed by: